Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 21, 2025
[Bayesian Regression Modeling of the Correlation between Post-Progression Survival and Overall Survival in Immune Checkpoint Inhibitor Therapy]
Motoko Kaneko, Toshihiro Shida, Yoshiki Abe, et al.
Japanese Journal of Clinical Oncology
|
February 1, 2018
Improved overall survival over recent decades in patients with hormone-receptor-positive, HER2-negative breast cancer: a single-center retrospective analysis of prognostic factors
Yoko Yamada, Hirofumi Mukai, Yuta Tokudome, et al.
International Archives of Allergy and Immunology
|
August 9, 2007
Mechanism for the differentiation of EoL-1 cells into eosinophils by histone deacetylase inhibitors
Motoko Kaneko, Kenji Ishihara, Aki Takahashi, et al.
Life Sciences
|
January 30, 2007
Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors
Kenji Ishihara, Aki Takahashi, Motoko Kaneko, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 23, 2023
Cost-Effectiveness Analysis of Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib for Inoperable or Recurrent Breast Cancer
Toshihiro Shida, Motoko Kaneko, Jiro Ogura, et al.
Biochemical and Biophysical Research Communications
|
December 19, 2007
Mechanisms for the proliferation of eosinophilic leukemia cells by FIP1L1-PDGFRalpha
Kenji Ishihara, Hajime Kitamura, Kenji Hiraizumi, et al.
International Archives of Allergy and Immunology
|
June 25, 2008
Mechanism for the decrease in the FIP1L1-PDGFRalpha protein level in EoL-1 cells by histone deacetylase inhibitors
Kenji Ishihara, Motoko Kaneko, Hajime Kitamura, et al.
Anticancer Research
|
June 29, 2026
Association Between Brachytherapy and Acute Diarrhea During Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study
Masaki Nakai, Kensuke Yoshida, Hajime Morita, et al.
Scientific Reports
|
October 28, 2025
Development and validation of predictive model for emesis in cervical cancer patients receiving concurrent chemoradiotherapy based on multi-institutional retrospective study
Kensuke Yoshida, Hajime Morita, Masaki Nakai, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 21, 2025
[Bayesian Regression Modeling of the Correlation between Post-Progression Survival and Overall Survival in Immune Checkpoint Inhibitor Therapy]
Motoko Kaneko, Toshihiro Shida, Yoshiki Abe, et al.
Japanese Journal of Clinical Oncology
|
February 1, 2018
Improved overall survival over recent decades in patients with hormone-receptor-positive, HER2-negative breast cancer: a single-center retrospective analysis of prognostic factors
Yoko Yamada, Hirofumi Mukai, Yuta Tokudome, et al.
International Archives of Allergy and Immunology
|
August 9, 2007
Mechanism for the differentiation of EoL-1 cells into eosinophils by histone deacetylase inhibitors
Motoko Kaneko, Kenji Ishihara, Aki Takahashi, et al.
Life Sciences
|
January 30, 2007
Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors
Kenji Ishihara, Aki Takahashi, Motoko Kaneko, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 23, 2023
Cost-Effectiveness Analysis of Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib for Inoperable or Recurrent Breast Cancer
Toshihiro Shida, Motoko Kaneko, Jiro Ogura, et al.
Biochemical and Biophysical Research Communications
|
December 19, 2007
Mechanisms for the proliferation of eosinophilic leukemia cells by FIP1L1-PDGFRalpha
Kenji Ishihara, Hajime Kitamura, Kenji Hiraizumi, et al.
International Archives of Allergy and Immunology
|
June 25, 2008
Mechanism for the decrease in the FIP1L1-PDGFRalpha protein level in EoL-1 cells by histone deacetylase inhibitors
Kenji Ishihara, Motoko Kaneko, Hajime Kitamura, et al.
Anticancer Research
|
June 29, 2026
Association Between Brachytherapy and Acute Diarrhea During Chemoradiotherapy for Cervical Cancer: A Multicenter Retrospective Study
Masaki Nakai, Kensuke Yoshida, Hajime Morita, et al.
Scientific Reports
|
October 28, 2025
Development and validation of predictive model for emesis in cervical cancer patients receiving concurrent chemoradiotherapy based on multi-institutional retrospective study
Kensuke Yoshida, Hajime Morita, Masaki Nakai, et al.
Page
of 1